Cargando…

Neuronal RNA‐binding protein dysfunction in multiple sclerosis cortex

OBJECTIVE: Neurodegeneration is thought to be the primary cause of neurological disability in multiple sclerosis (MS). Dysfunctional RNA‐binding proteins (RBPs) including their mislocalization from nucleus to cytoplasm, stress granule formation, and altered RNA metabolism have been found to underlie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salapa, Hannah E., Hutchinson, Catherine, Popescu, Bogdan F., Levin, Michael C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359129/ https://www.ncbi.nlm.nih.gov/pubmed/32608162 http://dx.doi.org/10.1002/acn3.51103

Ejemplares similares

The Potential Contribution of Dysfunctional RNA-Binding Proteins to the Pathogenesis of Neurodegeneration in Multiple Sclerosis and Relevant Models
por: Libner, Cole D., et al.
Publicado: (2020)

Antibodies to the RNA Binding Protein Heterogeneous Nuclear Ribonucleoprotein A1 Colocalize to Stress Granules Resulting in Altered RNA and Protein Levels in a Model of Neurodegeneration in Multiple Sclerosis
por: Douglas, Joshua N., et al.
Publicado: (2016)

Contribution of the Degeneration of the Neuro-Axonal Unit to the Pathogenesis of Multiple Sclerosis
por: Salapa, Hannah E., et al.
Publicado: (2017)

Multiple Sclerosis-Associated hnRNPA1 Mutations Alter hnRNPA1 Dynamics and Influence Stress Granule Formation
por: Clarke, Joseph-Patrick W. E., et al.
Publicado: (2021)

Pro-Inflammatory Cytokines and Antibodies Induce hnRNP A1 Dysfunction in Mouse Primary Cortical Neurons
por: Li, Muxue, et al.
Publicado: (2021)

Sequence- and structure-specific RNA oligonucleotide binding attenuates heterogeneous nuclear ribonucleoprotein A1 dysfunction
por: Clarke, Joseph P., et al.
Publicado: (2023)

Knock-Down of Heterogeneous Nuclear Ribonucleoprotein A1 Results in Neurite Damage, Altered Stress Granule Biology, and Cellular Toxicity in Differentiated Neuronal Cells
por: Anees, Amber, et al.
Publicado: (2021)

A Tripartite Knowledge Translation Program: Innovative Patient-Centered Approach to Clinical Research Participation for Individuals with Multiple Sclerosis
por: Saini, Aman, et al.
Publicado: (2021)

A Comprehensive Analysis of the Role of hnRNP A1 Function and Dysfunction in the Pathogenesis of Neurodegenerative Disease
por: Clarke, Joseph P., et al.
Publicado: (2021)

The snowball effect of RNA binding protein dysfunction in amyotrophic lateral sclerosis
por: Fratta, Pietro, et al.
Publicado: (2018)

Novel somatic single nucleotide variants within the RNA binding protein hnRNP A1 in multiple sclerosis patients
por: Lee, Sangmin, et al.
Publicado: (2014)

Antibodies to the RNA-binding protein hnRNP A1 contribute to neurodegeneration in a model of central nervous system autoimmune inflammatory disease
por: Douglas, Joshua N., et al.
Publicado: (2016)

Meningeal and cortical grey matter pathology in multiple sclerosis
por: Gh Popescu, Bogdan F, et al.
Publicado: (2012)

Localization of near-infrared labeled antibodies to the central nervous system in experimental autoimmune encephalomyelitis
por: Lee, Sangmin, et al.
Publicado: (2019)

RNA-binding proteins as a common ground for neurodegeneration and inflammation in amyotrophic lateral sclerosis and multiple sclerosis
por: Acosta-Galeana, Isabel, et al.
Publicado: (2023)

Regional motor cortex dysfunction in amyotrophic lateral sclerosis
por: Menon, Parvathi, et al.
Publicado: (2019)

Mitochondrial dysfunction and neurodegeneration in multiple sclerosis
por: Su, Kimmy, et al.
Publicado: (2013)

RNA-Binding Proteins in Amyotrophic Lateral Sclerosis
por: Zhao, Melody, et al.
Publicado: (2018)

Cognitive Dysfunction in Multiple Sclerosis
por: Guimarães, Joana, et al.
Publicado: (2012)

Mitochondrial Dysfunction and Multiple Sclerosis
por: de Barcelos, Isabella Peixoto, et al.
Publicado: (2019)

Cerebellar Dysfunction in Multiple Sclerosis
por: Wilkins, Alastair
Publicado: (2017)

Synapse Dysfunctions in Multiple Sclerosis
por: Schwarz, Karin, et al.
Publicado: (2023)

The Blood–Brain Barrier—A Key Player in Multiple Sclerosis Disease Mechanisms
por: Schreiner, Thomas Gabriel, et al.
Publicado: (2022)

Sex differences in the neuronal transcriptome and synaptic mitochondrial function in the cerebral cortex of a multiple sclerosis model
por: Itoh, Noriko, et al.
Publicado: (2023)

Contribution of RNA/DNA Binding Protein Dysfunction in Oligodendrocytes in the Pathogenesis of the Amyotrophic Lateral Sclerosis/Frontotemporal Lobar Degeneration Spectrum Diseases
por: Valori, Chiara F., et al.
Publicado: (2021)

Natalizumab: A new treatment for relapsing remitting multiple sclerosis
por: Hutchinson, Michael
Publicado: (2007)

RNA-Binding Proteins in Amyotrophic Lateral Sclerosis and Neurodegeneration
por: Ugras, Scott E., et al.
Publicado: (2012)

Dysregulation of RNA-Binding Proteins in Amyotrophic Lateral Sclerosis
por: Xue, Yuan Chao, et al.
Publicado: (2020)

Cuprizone and EAE mouse frontal cortex proteomics revealed proteins altered in multiple sclerosis
por: Oveland, Eystein, et al.
Publicado: (2021)

Cognitive dysfunction in pediatric multiple sclerosis
por: Suppiej, Agnese, et al.
Publicado: (2014)

Cognitive Dysfunctions and Assessments in Multiple Sclerosis
por: Oreja-Guevara, Celia, et al.
Publicado: (2019)

Hyperhomocysteinemia and Endothelial Dysfunction in Multiple Sclerosis
por: Dubchenko, Ekaterina, et al.
Publicado: (2020)

Sexual dysfunction in men with multiple sclerosis
por: Grech, Lisa B., et al.
Publicado: (2021)

hnRNP A/B Proteins: An Encyclopedic Assessment of Their Roles in Homeostasis and Disease
por: Thibault, Patricia A., et al.
Publicado: (2021)

Dysfunction of RNA/RNA-Binding Proteins in ALS Astrocytes and Microglia
por: Rossi, Simona, et al.
Publicado: (2021)

Antibodies from serum and CSF of multiple sclerosis patients bind to oligodendroglial and neuronal cell-lines
por: Nazir, Faisal Hayat, et al.
Publicado: (2023)

Neuron-binding antibody responses are associated with Black ethnicity in multiple sclerosis during natalizumab treatment
por: Telesford, Kiel M, et al.
Publicado: (2023)

Characteristic Personality Traits of Multiple Sclerosis Patients—An Unicentric Prospective Observational Cohort Study
por: Davidescu, Eugenia Irene, et al.
Publicado: (2021)

Linking Microstructural Integrity and Motor Cortex Excitability in Multiple Sclerosis
por: Radetz, Angela, et al.
Publicado: (2021)

RNA-Binding Proteins: Emerging Therapeutics for Vascular Dysfunction
por: Cornelius, Victoria A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v7gdpouhilml1p9smce76lcuo5